Webinar Overview

Choosing the right animal species is a crucial element to developing a nonclinical strategy for toxicology studies because if the drug is pharmacologically active in said species, it can predict any adverse effects that drug may have in patients. So what happens when there isn’t a relevant species available?

This webinar will delve into the various approaches when developing nonclinical strategies for therapeutics being used in foreign targets, such as bacterial, viral, and non-expressing human targets.

 

Scientific Moderator and Presenters

Peter Gaskin, PhD, ERT, MTOPRA
Senior Director of Scientific Advisory Services
Charles River

Jenny Sims, PhD
Founder and Director
Integrated Biologix

Magnus Nicholson, FRSC, FRSM
Chief Operating Officer
Invizius

 

View the other webinars in the series:

 

During this time of uncertainty, we are focused on providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.